
    
      The information obtained from this trial will help determine the feasibility and safety of
      administering docetaxel at various dosing levels on a bi-weekly schedule in this patient
      population. If the data from this phase I trial are encouraging, a phase II trial will be
      conducted to further assess the efficacy of this dosing schedule.
    
  